Silver Book Fact

Investments in cancer care generated $598 billion of additional value for cancer patients diagnosed between 1983 and 1999.

Philipson, T, M Eber, D Lakdawalla, M Corral, R Conti, and D Goldman. An Analysis of Whether Higher Health Care Spending is ?Worth it? in the Case of Cancer. Health Affairs. 2012; 31(4): 667-75. http://content.healthaffairs.org/content/31/4/667.abstract

Reference

Title
An Analysis of Whether Higher Health Care Spending is ?Worth it? in the Case of Cancer
Publication
Health Affairs
Publication Date
2012
Authors
Philipson, T, M Eber, D Lakdawalla, M Corral, R Conti, and D Goldman
Volume & Issue
Volume 31, Issue 4
Pages
667-75
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • The increase in the stock of cancer drugs from 1975 to 1995 accounted for about 50 to 60 percent of the increase in age-adjusted survival rates in the first 6…  
  • Increased use of medical technology, like colonoscopy and sigmoidoscopy for colon cancer screening, could save $178.2 billion between 2010 and 2035.  
  • Between 2008 and 2010, use of colonoscopy for the treatment and prevention of colon cancer saved an average of $150,364 each year, per person affected.  
  • Close to one third of all drugs currently in the biopharmaceutical pipeline are for cancer, with around 5,500 potential first-in-class cancer medicines in development.  
  • Investments in cancer research and development between 1998 and 2000 has generated 23 million additional healthy years of life and $1.9 trillion of additional social value.